Cipla stock jumps to all-time high; Nuvama raises target price, sees 18% upside
Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.
Stay updated with breaking news from Cipla Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.
Stocks to watch: Shares of firms like RIL, IRCTC, IndiGo, Apollo Tyres, Cipla, BHEL, Nazara Tech, and others will be in focus on Wednesday's trade.
How And When To Administer COVID Antibody Cocktail Drug Jun 01, 2021, 15:19 IST An 84-year-old man from Haryana became the first person in India to be administered the Covid drug cocktail over a 30 minute intravenous supply and has now been successfully used in various parts of the country. This treatment first came into the limelight after it was administered to former US President Donald Trump when he tested positive for Covid last year. The cocktail drug is a combination of two fast-acting antibodies - Casirivimab and Imdevimab - is seen as a cutting-edge treatment that provides pr...